SG
Scott T Garrett
Director

Scott T Garrett insider trades: HCW Biologics (HCWB) stock buys and sales

Director, HCW Biologics Last trade Jul 29, 2026 174 Form 4 filings
$0
Sold, last 12 months
0 sales
$270K
Bought, last 12 months
2 buys
9
Open-market trades
since 2005
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 29, 2026HCWB↑ Buy$20K
May 22, 2026HCWB↑ Buy$250K
May 16, 2025HCWB↑ Buy$100K
May 8, 2025HCWB↑ Buy$140K
Mar 14, 2024HOLX↓ Sell$1.2M
Dec 11, 2023HOLX↓ Sell$687K
Jun 15, 2023HOLX↓ Sell$797K
Jul 22, 2021HCWB↑ Buy$1.0M
Aug 17, 2005BEC↑ Buy$539K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other HCWB insiders

Open-market trades in the last 12 months

About Scott T Garrett's insider trades

Scott T Garrett is a director at HCW Biologics (HCWB). Since Aug 17, 2005, Scott has reported 6 open-market purchases worth $2.0M and 3 sales worth $2.7M on SEC Form 4. In the last 12 months: 2 buys ($270K).

Their filings also include grants and awards (154 filings), option exercises (8 filings), shares withheld for taxes (8 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCWB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.